Home  »  Equity Investing   »  What Caused The Novo Integrated Sciences (NVOS) St...

What Caused The Novo Integrated Sciences (NVOS) Stock To Rise Pre-Hours?

Shares of Novo Integrated Sciences Inc. (NASD: NVOS) are up today in pre-market trading at $0.2885. After losing -4.07% to end the regular trading session at $0.28, NVOS has risen 7.74% to $0.305 in the after-hours market on Wednesday.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


What current events took place at NVOS?

Last week, Novo Integrated Sciences (NVOS) disclosed the pricing for its public offering of a total of 4,000,000 shares at a price of $0.50 per unit. There is one share of common stock for each unit (or one pre-funded warrant in lieu thereof). Furthermore, it consists of two warrants: one warrant to buy one share of common stock, immediately exercisable at a price of $0.50 per share and expiring five years after the date of issuance; and one warrant, which will immediately separate upon issuance, to buy one share of common stock, immediately exercisable at a price of $0.50 per share and expire three years after the date of issuance.

Depending on the fulfillment of customary closing conditions, the offering’s closing was projected to take place on or around October 18, 2022. Before subtracting the placement agent’s commission and other selling costs, it was anticipated that the total proceeds from the offering would be close to $2.0 million. The Company had plans to use the net proceeds of the offering for general business objectives, including potential future strategic acquisitions, debt reduction, and other company-wide needs. The only placement agent for the offering is Maxim Group LLC which was represented by Harter Secrest & Emery LLP, while Novo Integrated Sciences was represented by Anthony L. G., PLLC.

Recently, NVOS inked a contract:

Through its fully owned subsidiary Clinical Consultants International (‘CCI’), Novo also this month announced the signing of a Consulting Services Agreement (the “Agreement”). With Softhread, Inc., an information technology firm that provides a proprietary, patent-pending blockchain and AI-enabled platform that maintains confidentiality and enhances network security while boosting operational efficiency, the Agreement includes the possibility of revenue sharing. The Agreement refers to Softhread’s product and service offerings relevant to the quickly changing worldwide medical communities as they enter the new era of connected, smart healthcare delivery, or “Health Care 4.0.”

What made it easier for NVOS to get the deal?

The CCI team continues to give Novo Integrated Sciences (NVOS) access to crucial medical community contacts both domestically and abroad. Cybersecurity, artificial intelligence, and blockchain architecture are all crucial elements of substantially enhancing the privacy, security, and speed of data management in networks as the healthcare business accepts the fundamental transformation of smart and connected healthcare delivery. Through this Agreement, Softhread’s award-winning, recognized technologists and business executives will collaborate with CCI’s team of highly regarded, established medical professionals, led by Dr. Chalil, to introduce the Softhread platform to the medical community globally.

Leave a Comment

Your email address will not be published. Required fields are marked *

Related Posts




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam